Search Results - "Nanomedicine"

Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between "seed and soil" by Junyu Wu, Yang Long, Man Li, Qin He

Connect to this object online.

Tear exosome‐based PROteolysis TArgeting Chimeras nanomedicine for human immunodeficiency virus‐mediated cancer treatment by Nobendu Mukerjee

Connect to this object online.

Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture by Suhair Sunoqrot, Malek Alfaraj, Ala'a M. Hammad, Violet Kasabri, Dana Shalabi, Ahmad A. Deeb, Lina Hasan Ibrahim, Khaldoun Shnewer, Ismail Yousef

Connect to this object online.

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine by Hong Y, Che S, Hui B, Wang X, Zhang X, Ma H

Connect to this object online.

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy by Marina R. Tavares, Klára Hrabánková, Rafał Konefał, Martin Kaňa, Blanka Říhová, Tomáš Etrych, Milada Šírová, Petr Chytil

Connect to this object online.

Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development by Yixin Sun, Dongyang Zhao, Gang Wang, Yang Wang, Linlin Cao, Jin Sun, Qikun Jiang, Zhonggui He

Connect to this object online.

Charge-reversal nanomedicine based on black phosphorus for the development of A Novel photothermal therapy of oral cancer by Zimu Li, Qingyun Liu, Yi Zhang, Yao Yang, Xiaomin Zhou, Wei Peng, Zhigang Liang, Xiaowei Zeng, Qiuxu Wang, Nansha Gao

Connect to this object online.

Exploring the Frontier of Biopolymer-Assisted Drug Delivery: Advancements, Clinical Applications, and Future Perspectives in Cancer Nanomedicine by Alharbi HM

Connect to this object online.

Nanomedicine-mediated prevention of inflammatory monocytes infiltration ameliorate ovalbumin-induced allergic rhinitis in mouse model by Xiaofeng Gu, Feng Xiao, Wenmin Lu, Ying Xu, Xia Li, Chenjie Yu, Xinyan Cui

Connect to this object online.

Preparation and characterization of capsaicin encapsulated polymeric micelles and studies of synergism with nicotinic acids as potential anticancer nanomedicines by Rawan Shamsheer, Suhair Sunoqrot, Violet Kasabri, Dana Shalabi, Rema Alkhateeb, Yusuf Alhiari, Riad Ababneh, Balqis Ikhmais, Hamza Abumansour

Connect to this object online.

GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine by Lei Luo, Yiming Qi, Hong Zhong, Shinan Jiang, Hu Zhang, Hao Cai, Yahui Wu, Zhongwei Gu, Qiyong Gong, Kui Luo

Connect to this object online.

A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics by Liyu Zhang, Meng Wang, Zeen Zhu, Shengquan Chen, Haibin Wu, Ying Yang, Fengyu Che, Qiao Li, Hui Li

Connect to this object online.

Dopamine and Citicoline-Co-Loaded Solid Lipid Nanoparticles as Multifunctional Nanomedicines for Parkinson's Disease Treatment by Intranasal Administration by Stefano Castellani, Giorgia Natalia Iaconisi, Francesca Tripaldi, Vito Porcelli, Adriana Trapani, Eugenia Messina, Lorenzo Guerra, Cinzia Di Franco, Giuseppe Maruccio, Anna Grazia Monteduro, Filomena Corbo, Sante Di Gioia, Giuseppe Trapani, Massimo Conese

Connect to this object online.

Supramolecular Caffeic Acid and Bortezomib Nanomedicine: Prodrug Inducing Reactive Oxygen Species and Inhibiting Cancer Cell Survival by Ludwig Erik Aguilar, Se Rim Jang, Chan Hee Park, Kang Min Lee

Connect to this object online.

Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization by Ekaterina Sinitsyna, Irina Bagaeva, Erik Gandalipov, Evgenia Fedotova, Viktor Korzhikov-Vlakh, Tatiana Tennikova, Evgenia Korzhikova-Vlakh

Connect to this object online.

Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax by Thao M. Nguyen, Paul Joyce, David M. Ross, Kristen Bremmell, Manasi Jambhrunkar, Sook S. Wong, Clive A. Prestidge

Connect to this object online.

A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment by Ana Serrano-Martínez, Desirée Victoria-Montesinos, Ana María García-Muñoz, Pilar Hernández-Sánchez, Carmen Lucas-Abellán, Rebeca González-Louzao

Connect to this object online.

Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office by Diego Alejandro Dri, Elisa Gaucci, Ilaria Torrieri, Maria Carafa, Carlotta Marianecci, Donatella Gramaglia

Connect to this object online.

Brain-targeting delivery of MMB4 DMS using carrier-free nanomedicine CRT-MMB4@MDZ by Yimeng Du, Jing Gao, Hui Zhang, Xiaohui Meng, Dong Qiu, Xiang Gao, Aiping Zheng

Connect to this object online.

Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation by Airong Li, Chenglin Liang, Lihua Xu, Yiyang Wang, Wei Liu, Kaixiang Zhang, Junjie Liu, Jinjin Shi

Connect to this object online.